Protein A Resin Market Size, Share, Growth, Trends | Report 2023-2032
The global protein A resin market was valued at USD 1.36 billion in 2022 and it is predicted to surpass around USD 2.55 billion by 2032 with a CAGR of 6.49% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 1.36 billion |
| Revenue Forecast by 2032 | USD 2.55 billion |
| Growth rate from 2023 to 2032 | CAGR of 6.49% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | GE Healthcare; Merck Millipore; PerkinElmer, Inc.; GenScript Biotech Corp.; Agilent Technologies; Repligen Corp.; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Abcam PLC; Novasep Holdings SAS |
Protein A resins are used for the purification and fragmentation of the immunoglobulins from biological fluids & cell culture media, immunoprecipitation of proteins, and antigens. The major application of the protein A resin is monoclonal antibody production. Furthermore, the global industry is expanding as a result of an increase in the drug development process by the biotechnology & biopharmaceutical industries, growing studies in monoclonal antibodies, and increased expenditure in synthetic biology. Moreover, there is an increase in the demand for the protein-engineered products used for vaccine and therapeutics development by the biopharmaceutical industries, which has a positive impact on the global industry and is one of the major driving factors.
The COVID-19 pandemic has adversely affected the world economy by negatively affecting the supply chain of biopharmaceutical products, medical devices, and biotechnology products. On the other hand, the R&D sector and the development of therapeutics have flourished. Development of therapeutics & drug discovery requires accurate study and understanding of the structure and role of protein resins in the treatment of SARS-CoV-2 virus progression. However, the imposed lockdown led to the shutdown of the research institute and hampered the research studies.
Furthermore, various strategic initiatives have been implemented by key players to develop mAbs to treat COVID-19 virus infection. Therefore, biopharmaceutical and biotechnology companies are also engaged in collaboration and mergers for the development of vaccines for the COVID-19 virus treatment. For instance, in May 2021, Repligen collaborated with Navigo Proteins for developing NGL COVID-19 Spike Protein Affinity Resins to purify the COVID-19 vaccine. The resins bind to the SARS-CoV-2 spike protein binding domain and help in the purification of the vaccine. In addition, in June 2020, Kaneka Corp. collaborated with the National Institute of Infectious Diseases for the production of antibodies for treating novel coronavirus infections. This accelerated the development of therapeutic drugs for treating COVID-19 infection.
Protein A Resin Market Segmentations:
| By Type | By Product | By Application | By End-users |
|
Natural Protein A Recombinant Protein A |
Agarose-based Protein A Glass/Silica-based Protein A Organic Polymer-based Protein A |
Antibody Purification Immunoprecipitation |
Pharmaceutical & Biopharmaceutical Companies Academic Research Institutes Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Protein A Resin Market
5.1. COVID-19 Landscape: Protein A Resin Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Protein A Resin Market, By Type
8.1. Protein A Resin Market, by Type, 2023-2032
8.1.1. Natural Protein A
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Recombinant Protein A
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Protein A Resin Market, By Product
9.1. Protein A Resin Market, by Product, 2023-2032
9.1.1. Agarose-based Protein A
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Glass/Silica-based Protein A
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Organic Polymer-based Protein A
9.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Protein A Resin Market, By Application
10.1. Protein A Resin Market, by Application, 2023-2032
10.1.1. Antibody Purification
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Immunoprecipitation
10.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Protein A Resin Market, By End-users
11.1. Protein A Resin Market, by End-users, 2023-2032
11.1.1. Pharmaceutical & Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Academic Research Institutes
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Protein A Resin Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2019-2032)
12.1.2. Market Revenue and Forecast, by Product (2019-2032)
12.1.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.4. Market Revenue and Forecast, by End-users (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Product (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.6.4. Market Revenue and Forecast, by End-users (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2019-2032)
12.2.2. Market Revenue and Forecast, by Product (2019-2032)
12.2.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.4. Market Revenue and Forecast, by End-users (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Product (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.6.4. Market Revenue and Forecast, by End-users (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Product (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.7.4. Market Revenue and Forecast, by End-users (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Product (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.8.4. Market Revenue and Forecast, by End-users (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2019-2032)
12.3.2. Market Revenue and Forecast, by Product (2019-2032)
12.3.3. Market Revenue and Forecast, by Application (2019-2032)
12.3.4. Market Revenue and Forecast, by End-users (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.3.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Product (2019-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.3.6.4. Market Revenue and Forecast, by End-users (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Product (2019-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2019-2032)
12.3.7.4. Market Revenue and Forecast, by End-users (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Product (2019-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2019-2032)
12.3.8.4. Market Revenue and Forecast, by End-users (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2019-2032)
12.4.2. Market Revenue and Forecast, by Product (2019-2032)
12.4.3. Market Revenue and Forecast, by Application (2019-2032)
12.4.4. Market Revenue and Forecast, by End-users (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.4.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Product (2019-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.4.6.4. Market Revenue and Forecast, by End-users (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Product (2019-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2019-2032)
12.4.7.4. Market Revenue and Forecast, by End-users (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Product (2019-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2019-2032)
12.4.8.4. Market Revenue and Forecast, by End-users (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Product (2019-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.5.5.4. Market Revenue and Forecast, by End-users (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Product (2019-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.5.6.4. Market Revenue and Forecast, by End-users (2019-2032)
Chapter 13. Company Profiles
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Merck Millipore
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PerkinElmer, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. GenScript Biotech Corp.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Repligen Corp.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Thermo Fisher Scientific, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Abcam PLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Novasep Holdings SAS
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers